Find a Trial

Trial Results


9 protocol(s) meet the specified criteria
9812-11OPEN TO ACCRUAL
Laboratory Studies of Peripheral Blood and Bone Marrow Cells Isolated from Patients with Clonal Myeloid or Lymphoproliferative Disorders
IUCRO-0216OPEN TO ACCRUAL
Indiana University Simon Cancer Center Hematologic Malignancies Tissue Bank
IUCRO-0476OPEN TO ACCRUAL
A Study of the Effect of Sirolimus Levels on Incidence of Hepatic Sinusoidal Obstructive Syndrome
NURS-IUSCC-0720OPEN TO ACCRUAL
Biologic Mechanisms and Dosing of Active Music Engagement in Children with Acute Lymphoblastic Leukemia and Parents
PHO-COG-AALL1732OPEN TO ACCRUAL
A Phase 3 Randomized Trial of Inotuzumab Ozogamicin (IND#:133494, NSC#: 772518) for Newly Diagnosed High-Risk B-ALL; Risk-Adapted Post-Induction Therapy for High-Risk B-ALL, Mixed Phenotype Acute Leukemia, and Disseminated B-LLy
PHO-COG-AALL1821OPEN TO ACCRUAL
AALL1821, A Phase 2 Study of Blinatumomab (NSC # 765986, IND # 125462) in Combination with Nivolumab (NSC # 748726, IND # 125462), a Checkpoint Inhibitor of PD-1, in B-ALL Patients Aged equal to or more than 1 to less than 31 Years Old with First Relapse.
PHO-COG-AAML18P1OPEN TO ACCRUAL
Stopping Tyrosine Kinase Inhibitors (TKI) to Assess Treatment-Free Remission (TFR) in Pediatric Chronic Myeloid Leukemia - Chronic Phase (CML-CP)
PHO-IIR-COGNITIVE-INTERVENTIONOPEN TO ACCRUAL
Feasibility of a Cognitive Intervention in Pediatric Survivors of Acute Lymphoblastic Leukemia.
PHO-PRADHAN-COG-AALL1631OPEN TO ACCRUAL
International Phase 3 trial in Philadelphia chromosome-positive acute lymphoblastic leukemia (Ph+ ALL) testing imatinib in combination with two different cytotoxic chemotherapy backbones